Abstract. Dysfunction of the yes-associated protein (YAP) signaling pathway has previously been associated with liver tumorigenesis. Recently, the membrane protein melanoma cell adhesion molecule (MCAM) was identified as a novel, hepatocellular carcinoma (HCC)-specific YAP target protein that promotes carcinogenesis in HCC. However, whether MCAM conversely regulates YAP remains unknown. The aim of the current study was to demonstrate whether and how MCAM regulates YAP in HCC cells. The present study demonstrated that MCAM has a positive effect on the regulation of YAP activity and expression. Mechanistically, MCAM stimulated YAP transcription through its downstream effector c-Jun/ c-Fos heterodimer. Gain and loss of function analysis by the present study indicated that c-Jun/c-Fos is capable of inducing cAMP response element-binding protein activation, which is a transcription factor that directly binds to the YAP promoter. Finally, it was identified that an impaired transformative phenotype in MCAM-or c-Jun/c-Fos-depleted HCC cells could be partially rescued by simultaneous overexpression of YAP, suggesting that YAP may function as a downstream effector of the MCAM-c-Jun/c-Fos signaling pathway. Collectively, a complete, positive, auto-regulatory loop was established by the present study, in which YAP is not only an upstream regulator, but also a downstream target of MCAM in HCC cells.
Introduction
Hepatocellular carcinoma (HCC) is one of the most prevalent types of cancer worldwide (1) with an incidence rate of 10.1 cases per 100,000 individuals and a mortality rate of 9.5 cases per 100,000 individuals (2) . Previously, dysfunction of the yes-associated protein (YAP) signaling pathway has been associated with liver tumorigenesis (3), and liver-specific YAP overexpression in transgenic mice resulted in tumor development (4). In addition, clinical studies have demonstrated that YAP is overexpressed and is a predictor of poor survival in patients with HCC (5) . Due to the key role YAP is considered to play in liver tumorigenesis, it is extremely important to understand how this protein is regulated in HCC cells. A previous study established the role of cAMP response element-binding protein (CREB) in the upregulation of YAP in HCC cells, and identified a novel CREB binding site within the YAP promoter region (6) . However, whether and how other proteins stimulate CREB-dependent transcription of YAP remains unclear.
Functioning as a cofactor, YAP increases the transcriptional activities of various transcription factors, including TEA domain (TEAD) family (7) . Although several YAP target genes that operate in liver tumorigenesis have been gradually identified (8, 9) , a large number remain unknown. Previously, the membrane protein, melanoma cell adhesion molecule (MCAM), was established as a novel HCC-specific YAP target (10) . MCAM serum levels have been revealed to be specifically increased in HCC, indicating that MCAM serum levels may function as a specific tumor marker for HCC (10) . In addition, it was demonstrated that MCAM is essential for HCC cell transformation and survival through the promotion of pro-tumorigenic c-Jun/c-Fos protein function (10) . However, whether and how MCAM conversely regulates YAP function requires additional investigation.
The aim of the present study was to demonstrate whether MCAM regulates YAP in HCC cells and how this mechanism occurs. The present study demonstrated that MCAM is key in the stimulation of CREB-dependent transcription of YAP via the MCAM downstream effector c-Jun/c-Fos, and that YAP is a downstream effector of MCAM and c-Jun/c-Fos in the ; Thermo Fisher Scientific, Inc., Waltham, MA, USA) at 37˚C in an incubator with 5% CO 2 . Small hairpin RNAs (shRNAs) against MCAM (sh1 and sh2), c-Fos and c-Jun were purchased from GeneChem Co., Ltd. (Shanghai, China). The cDNA fragments encoding human MCAM were purchased from OriGene Technologies, Inc. (Beijing, China), and subcloned into a pcDNA3.1(+) vector (Invitrogen™; Thermo Fisher Scientific, Inc.) as previously described (10) . The human c-Fos-and c-Jun-expressing vectors were purchased from OriGene Technologies, Inc.
Luciferase reporters containing either a CREB binding site (CREB-reporter) or a core YAP promoter region (YAP-promoter) were constructed as described previously (6, 11) . The TEAD-Gal4/pUAS-Luc system was provided by Dr Junhao Mao (University of Massachusetts, Worcester, MA, USA) from the authors' previous study (12) , and was used to indirectly test YAP activity, since YAP binds to the TEAD transcription factor. The YAP-expressing plasmids were constructed as described in a previous study (6) . Briefly, the open reading frame of YAP was polymerase chain reaction (PCR)-amplified using the following primers: YAP, forward 5'-ATG CGC TAG CGA TCC CGG GCA GCA GCC GCC GCC TC-3' and reverse 5'-ATG CGG CCG CCT ATA ACC ATG TAA GAA AGC TTT CTT TAT C-3'. The cDNA of Bel-7402 cells was used as the template, and a pGIZ2a-lentiviral-based vector (provided by Dr Junhao Mao) was used as the backbone.
Immunofluorescence. Glass slides were seeded with Bel-7402 cells and were fixed by 4% paraformaldehyde (Scigen Ltd, Shanghai, China) for 15 min, followed by washing with phosphate-buffered saline (PBS) for 5 min three times. Subsequently, the cells were incubated with blocking buffer [PBS solution containing 3% FBS, 1% goat serum (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA) and 0.1% Triton X-100 (Sangon Biotech Co., Ltd., Shanghai, China)] for 2 h at room temperature prior to incubation with primary antibodies overnight at 4˚C. ) and recorded on X-ray films. YAP protein levels were normalized to those of GAPDH and p-CREB levels were normalized to those of total CREB. Densitometry of the blots was performed using ImageJ version 1.47 software (National Institutes of Health, Bethesda, MD, USA).
Luciferase reporter analysis. Luciferase reporter plasmids were transiently transfected into Bel-7402, SMMC-7721 or Huh7 cells using Lipofectamine ® 2000 (Invitrogen™; Thermo Fisher Scientific, Inc.). pRL-TK (Promega Corporation, Madison, WI, USA) was co-transfected as an internal control to calibrate transfection efficiency. Following additional cultivation for 24 h, the transfected cells were harvested and lysed used 1X passive lysis buffer, centrifuged at 15,000 x g for 10 min and the pellet subjected to luciferase assay. Luciferase activity was measured as chemiluminescence using a plate reader (Σ960; Metertech, Inc., Taipei, Taiwan) and the Dual-Luciferase ® Reporter Assay System (Promega Corporation), according to the manufacturer's protocol. Firefly luciferase activities were normalized to those from Renilla.
Reverse transcription-quantitative PCR (qPCR).
Total RNA from Bel-7402, SMMC-7721 and Huh7 cells was extracted using TRIzol Reagent (Invitrogen™; Thermo Fisher Scientific, Inc.). In total, 20 ml reaction mixture was used to reverse transcribe 1 mg total RNA to cDNA using PrimeScript RT Reagent kit (Takara, Bio, Inc., Otsu, Japan). qPCR was performed on the cDNA using primers specific for YAP. The primers were purchased from BGI Shenzhen (Shenzhen, China) and were as follows: YAP, forward 5'-CCT CGT TTT GCC ATG AAC CAG-3' and reverse 5'-GTT CTT GCT GTT TCA GCC GCA G-3'; GAPDH, forward 5'-ATC ATC CCT GCC TCT ACT GG-3' and reverse 5'-GTC AGG TCC ACC ACT GAC AC-3'. SYBR Green Mix kit (Takara Bio, Inc.) was used for the qPCR. The conditions for qPCR were as follows: Activation at 94˚C for 5 min, and then 40 cycles of denaturation at 94˚C for 30 sec and combined annealing and extension at 60˚C for 30 sec. The RT-qPCR was performed on an ABI 7500 Real-time PCR System (Applied Biosystems ® ; Thermo Fisher Scientific, Inc.). The fluorescence of each sample was determined following every cycle. Relative expression levels were calculated as the ratios normalized against those of GAPDH, using the ∆Cq method. The ∆Cq value was determined by subtracting the GAPDH ∆Cq value from the YAP gene ∆Cq value. The ∆Cq of the stimulated cells (∆Cqt) was subtracted from the ∆Cq of the untreated cells (∆Cqu) as follows: ∆∆Cq = ∆Cqt -∆Cqu. The expression level for the YAP gene in the stimulated cells compared with the level in the untreated cells was calculated as follows: x-fold of unstimulated control = 2 -∆∆Cq (13) .
Chromatin immunoprecipitation (ChIP).
ChIP assays were performed with the ChIP-IT ® Express kit (catalog no., 53008; Active Motif, Carlsbad, CA, USA), according to the manufacturer's protocol. Briefly, 1x10 7 cells were fixed with 1% formaldehyde, washed with cold PBS and lysed in 1X lysis buffer. Nuclei were sonicated (JY92-IIN; Scientz Biotech Co., Ltd., Ningbo, China) to shear DNA, and the lysates were pelleted and precleared using A/G beads (Novex ® ; Thermo Fisher Scientific, Inc.). The beads were separated by centrifugation at 15,000 x g for 20 min and the protein-DNA complexes were incubated with 3 µg rabbit monoclonal anti-CREB antibody and 10 µl protein A/G beads in a total reaction mixture of 200 µl overnight at 4˚C. The protein-DNA complexes were eluted in 1% SDS/0.1 M NaHCO 3 and cross-links were reversed at 65˚C. Finally, DNA was subjected to qPCR analysis following recovery using a SYBR Green Mix kit (Takara, Bio, Inc.) and an ABI 7500 Real-time PCR System (Applied Biosystems ® ; Thermo Fisher Scientific, Inc.) with the following cycling conditions: 94˚C for 5 min, then 40 cycles of 94˚C for 30 sec, and 60˚C for 30 sec. The primers were purchased from BGI Shenzhen and were used for detection of CREB binding on the YAP promoter (R1 and R2), as follows: R1, forward 5'-CCA ACA ACT ATG AGG TAG GTG-3' and reverse 5'-GAG TTT TGA GTT CAG GTC CCA GTT C-3'; R2, forward 5'-GCA GAC TAA CAG ATA AGT GAA AC-3' and reverse 5'-TCC GCT CCG CTC GGC CCC TTT TC-3'. The fluorescence of each sample was determined following every cycle. Relative enrichments of CREB binding within the YAP promoter were calculated as the ratios normalized against those of the input sample, using the ΔCq method. The ΔCq value was determined by subtracting the input sample ΔCq value from the CREB ChIP sample ΔCq value. The percentage of input (%) was calculated as follows: 2 -∆∆Cq x 100% (11).
Soft-agar assays. Anchorage-independent soft-agar growth assays were performed as previously described (6 or c-Fos knocked-down, using shRNAs, in the presence or absence of overexpression of YAP were seeded onto 6-well agar plates at a density of 5x10 3 cells/well and maintained in DMEM supplemented with 1 µg/ml puromycin (Mediatech, Inc., Manassas, VA, USA) for 4 weeks until foci were evident. Colonies were subsequently counted.
Statistical analysis. Student's t-test was used to examine the differences between groups using STATA version 11.0 software (StataCorp LP, College Station, TX, USA). P<0.05 was considered to indicate a statistically significant difference. Results are expressed as the mean ± standard deviation of three independent experiments.
Results

MCAM conversely regulates YAP.
To investigate whether MCAM conversely regulates YAP, YAP protein expression was analyzed prior to and following knockdown or overexpression of MCAM. The results demonstrated that YAP protein levels were downregulated by MCAM-knockdown through two independent MCAM shRNAs (sh1 and sh2, respectively), whilst overexpression of MCAM resulted in upregulated YAP protein levels ( Fig. 1A and B) . Since TEAD transcription factors mediate YAP-dependent transcriptional activity (7), the present study utilized a previously reported pUAS-Luc-TEAD-Gal4 system (12) to indirectly test YAP activity prior to and following knockdown or overexpression of MCAM. It was demonstrated that TEAD-controlled downstream luciferase activities could be reduced significantly by MCAM-sh1 and -sh2, and could be induced by ectopically-expressed MCAM (Fig. 1C) , thus suggesting that MCAM also induces YAP activity. In addition, it was observed that MCAM had a similar effect on YAP mRNA as that on YAP protein (Fig. 1D) , indicating that MCAM regulates YAP expression primarily through its effect on YAP transcription. Fig. 2A and B ; P<0.05). Subsequently, whether c-Jun/c-Fos regulates YAP mRNA levels was analyzes, and it was observed that YAP mRNA levels were also upregulated by c-Jun/c-Fos (Fig. 2C) . By contrast, knocking down c-Jun and c-Fos led to a significant downregulation of YAP protein ( Fig. 2D and E; P<0.05). Data from the pUAS-Luc-TEAD-Gal4 system indicated that TEAD-controlled downstream luciferase activities may be upregulated in a dose-dependent manner by transfection of increasing concentrations of c-Jun/c-Fos, in addition to demonstrating that the simultaneous effects of c-Jun and c-Fos were synergic (Fig. 2F) . Conversely, TEAD-controlled downstream luciferase activities could be downregulated by c-Jun/c-Fos-knockdown (Fig. 2F) . Furthermore, immunofluorescence assays demonstrated that YAP expression levels were increased in Bel-7402 cells with a successful transfection of c-Jun/c-Fos-expressing plasmids compared with untransfected control cells (Fig. 2G) . These results suggest that the MCAM downstream effectors, c-Jun/c-Fos, may be critical in the MCAM-induced upregulation of YAP.
YAP is regulated by c-
YAP transcription is upregulated by c-Jun/c-Fos via activation of CREB.
The present study demonstrated that c-Jun/c-Fos upregulated YAP by enhancing its transcription, and it was also reported previously that CREB is critical in the transcription of YAP (6) . Therefore, the present study hypothesized that c-Jun/c-Fos may upregulate the transcription of YAP via (Fig. 3A) . By contrast, c-Jun/c-Fos-knockdown resulted in significantly reduced CREB-dependent luciferase activities ( Fig. 3A; P<0.05). In a similar manner to the CREB-reporter, c-Jun/c-Fos upregulated luciferase activities from the reporter containing the core YAP promoter regions (YAP-promoter) (Fig. 3A) .
As the phosphorylation of CREB at Ser-133 (p-CREB) is a characteristic of CREB activation (14) , the present study investigated whether c-Jun/c-Fos affects the phosphorylation of CREB. The results demonstrated that c-Jun/c-Fos-knockdown significantly downregulated p-CREB ( Fig. 3B and C; P<0.05), whilst overexpression of c-Jun/c-Fos resulted in significantly upregulated levels of p-CREB ( Fig. 3D and E; P<0 .05). These results suggest that c-Jun/c-Fos stimulates activation of CREB.
It was subsequently investigated whether c-Jun/c-Fos could directly stimulate recruitment of CREB onto the YAP promoter. It was observed that the co-overexpression of c-Jun and c-Fos induced a significant enrichment of CREB onto the R2 region, which contains a known CREB binding site, of the YAP promoter compared with single overexpression of c-Jun and c-Fos (Fig. 3F) . However, no CREB enrichment was detected at the R1 region (Fig. 3F) , which is a CREB-unrelated region. By contrast, c-Jun-and c-Fos-knockdown reduced recruitment of CREB onto the YAP promoter at the R2 region, whereas this had no effect on the R1 region (Fig. 3F) . These results indicate that c-Jun/c-Fos stimulates YAP transcription through the induction of CREB recruitment onto the YAP promoter. (Fig. 4A) . Furthermore, c-Jun/c-Fos-knockdown induced downregulation of colony formation, which could also be partially rescued by overexpression of YAP (Fig. 4B) . These results indicate that YAP is a potential downstream target of the MCAM-c-Jun/c-Fos signaling cascade, and the associations between MCAM, c-Jun/c-Fos and YAP may be critical during liver tumorigenesis.
Discussion
Recently, MCAM was identified as a direct target of YAP in HCC cells (10) . Additionally, in the present study, it was demonstrated that YAP expression could be conversely regulated by MCAM through its downstream effector, c-Jun/c-Fos. c-Jun and c-Fos proteins are able to form heterodimers, which are capable of promoting proliferation and neoplastic transformation (15) . Notably, c-Jun/c-Fos dimers bind with high affinity to cAMP response elements (CREs), which are CREB binding sites (15) . Furthermore, CREB is able to efficiently form a heterodimeric complex with c-Jun, and the interaction between the two proteins increases the repertoire of possible regulatory complexes that are important in the regulation of transcription (16) . Although no previous study has yet established a direct interaction between CREB and c-Fos, the present study observed that the synergic effects Therefore, the present study hypothesizes that c-Jun, c-Fos and CREB may scaffold into a complex, and the close interactions between these three proteins may be fundamental for the transcriptional regulation of certain genes, including YAP, in the promotion of tumorigenesis. The present study hypothesizes that the critical step during the regulation of YAP by MCAM is the phosphorylation of CREB at Ser-133, which is facilitated by c-Jun/c-Fos. Ser-133 may be phosphorylated by various kinases, including protein kinase B, ribosomal protein S6 kinase, mitogen-and stress-activated protein kinase and protein kinase C (17, 18) , with its phosphorylation promoting the activation of CREB (19, 20) . Despite no direct evidence to suggest that c-Jun/c-Fos proteins possess a kinase function, c-Jun/c-Fos are able to be phosphorylated by other kinases. It has been demonstrated that constitutive activation of the extracellular-signal-regulated kinase (ERK) signaling pathway activates c-Jun by phosphorylation, and thus contributes to tumorigenesis by increasing cell proliferation (21) . Furthermore, ERK signaling catalyzes the phosphorylation of c-Fos at Ser-374 (22, 23) . Notably, it was reported that ERK phosphorylation is associated with increased phosphorylation of CREB (24) . As ERK functions as a signal transmitter between the cytoplasm and nucleus, the overexpression of membrane-bound MCAM in HCC may attract ERK to translocate from the cytoplasm to CRE sites in the nucleus. With the aid of c-Jun/c-Fos, ERK may add a phosphate group onto CREB and consequently stimulate CREB-dependent YAP transcription. However, further investigation is required to fully elucidate the associations between MCAM, c-Jun/c-Fos and CREB.
In conclusion, the current study established a complete, positive, auto-regulatory loop between MCAM and YAP. Inhibition of this loop may serve as a possible target for the treatment of HCC.
